Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial

NCT04332666 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus
Respiratory Failure
Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
SARS-CoV-2

Interventions

DRUG: Angiotensin 1-7
DRUG: Placebos

Sponsor

Erasme University Hospital

Collaborators

[object Object]